beta-alanine has been researched along with c-peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brand, CL; Cherrington, AD; Edgerton, DS; Everett-Grueter, CA; Jacobsen, LO; Kristensen, K; Larsen, MO; Neal, DW; Nishimura, E; Rivera, N; Rodewald, T | 1 |
| Bergman, A; Erion, DM; Kazierad, DJ; Lee, DS; Rolph, T; Somayaji, V; Tan, B | 1 |
1 trial(s) available for beta-alanine and c-peptide
| Article | Year |
|---|---|
Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Alanine Transaminase; Amino Acids; Aspartate Aminotransferases; beta-Alanine; Blood Glucose; C-Peptide; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Pyrazoles; Receptors, Glucagon; Sulfonylurea Compounds | 2016 |
1 other study(ies) available for beta-alanine and c-peptide
| Article | Year |
|---|---|
A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dog.
Topics: Aniline Compounds; Animals; beta-Alanine; C-Peptide; Dogs; Dose-Response Relationship, Drug; Female; Gluconeogenesis; Glucose; Glycogenolysis; Liver; Male; Receptors, Glucagon | 2007 |